AustralianSuper’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107M Buy
1,137,143
+496,410
+77% +$49.5M 0.56% 48
2025
Q4
$63.3M Buy
640,733
+427,492
+200% +$41.4M 0.29% 72
2025
Q3
$18.1M Buy
+213,241
New +$16.9M 0.09% 147
2023
Q2
Sell
-467,640
Closed -$33.8M 283
2023
Q1
$33.8M Buy
467,640
+9,122
+2% +$714K 0.21% 85
2022
Q4
$36.5M Buy
458,518
+51,249
+13% +$3.92M 0.24% 84
2022
Q3
$27.1K Sell
407,269
-76,884
-16% -$5.68M 0.19% 86
2022
Q2
$36.8K Buy
484,153
+91,090
+23% +$6.92M 0.23% 87
2022
Q1
$31.2K Buy
393,063
+113,225
+40% +$8.24M 0.17% 91
2021
Q4
$20.1K Buy
279,838
+150,829
+117% +$10.2M 0.1% 120
2021
Q3
$8.87M Buy
+129,009
New +$9.8M 0.06% 164
2021
Q1
Sell
-34,392
Closed -$2.99M 159
2020
Q4
$2.99M Buy
+34,392
New +$2.98M 0.02% 127

Other funds holding INCY

AustralianSuper's INCY Position: Q1 2026 in Review

AustralianSuper increased its Incyte (INCY) stake by 77% in Q1 2026, buying an estimated $49.5M and bringing the position to 1,137,143 shares worth $107M. The position accounts for 0.56% of the portfolio, ranked #48.

AustralianSuper first reported a position in INCY in Q4 2020 and has held it in 11 quarters since. 812 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • AustralianSuper held 1,137,143 shares of Incyte worth $107M as of Q1 2026.
  • AustralianSuper bought 496,410 Incyte shares in Q1 2026, an estimated $49.5M.
  • Incyte made up 0.56% of AustralianSuper's portfolio in Q1 2026, its #48 holding.
  • AustralianSuper first reported a position in Incyte in Q4 2020 and has held it in 11 quarters since.
  • 812 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.